CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 44 enrolled
Drug / intervention
carvediloldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02056626
NCT02056626Phase 4Completed
CompareCT.gov

Conditioned Pharmacotherapeutic Effects in Hypertension

University of Rochester·interventional·Posted Feb 6, 2014·Updated Jul 9, 2019

In Brief

A Phase 4 clinical trial evaluating carvedilol for Hypertension. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The proposed research is designed to determine if the application of classical conditioning operations could influence the clinical effects of a regimen of antihypertensive drug therapy. It will be determined if, capitalizing on conditioned pharmacotherapeutic effects, patients can be effectively treated with smaller cumulative amounts of drug.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2014
Enrollment StartMar 1, 2011
Primary CompletionNov 30, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 7.7 yearsPosted 12.4 years ago

Interventions

carvediloldrug